论文部分内容阅读
PHC 预后很差。但也有少数PHC 患者可长期存活、甚至自行消退。近几年来,由于诊断技术的进步,早期、小肝癌的发现为手术切除和根治带来了希望,再加上一些新抗癌药的发现及投药方式的改进,均使PHC 预后有所改观。一、影响预后因素及判断预后的指标HCC 总的预后是差的,但亦有个体差异,汤钊猷等总结多年的经验认为;肿瘤生物学特性是决定预后的主要因素;机体对肿瘤的反应是影响预后的关键因;而及时、合理的治疗是改善预后的重要因素。一认为肿瘤细胞分化差者病程较分化好者为短,分化
PHC has a poor prognosis. However, there are also a small number of patients with PHC who have long-term survival and even self-remission. In recent years, due to advances in diagnostic technology, the discovery of early and small liver cancer has brought hope for surgical resection and radical treatment. In addition, the discovery of new anticancer drugs and the improvement of drug administration methods have all improved the prognosis of PHC. First, the prognostic factors and prognosis indicators HCC overall prognosis is poor, but there are also individual differences, Tang Shu and other years of experience concluded that: the biological characteristics of the tumor is the main factor in determining the prognosis; the body’s response to the tumor is affected The key cause of the prognosis is timely and reasonable treatment is an important factor in improving the prognosis. One thinks that the poor differentiation of tumor cells is shorter than the well-differentiated ones.